GlassScriptPhysician profile
Lee Trotter
NPI 1013986157
$4,223.17
in general payments reported to CMS, 2019-2025
14 companies · $48.99 in 2025
The $48.99 reported for 2025 was less than what a typical Pediatric Surgery provider received nationally (typical 2025 total: $136).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,335 · 2020: $1,314 · 2021: $28.17 · 2022: $108 · 2023: $66.89 · 2024: $323 · 2025: $48.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $439.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,002.80 | 2019-2020 | |
| Allergan, INC. | $1,002.26 | 2019 | |
| Kci USA, INC. | $793.41 | 2019 | |
| Medical Device Business Services, INC. | $765.61 | 2020 | |
| Medtronic, INC. | $149.79 | 2021-2024 | Venaseal |
| Solventum Corporation | $134.74 | 2024 | Prevena, V.A.C. Dermatac, Activ.A.C. |
| Zimmer Biomet Holdings, INC. | $107.75 | 2020-2022 | |
| Tela Bio, INC. | $63.50 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Acera Surgical, INC. | $60.49 | 2023-2025 | Restrata Wound Matrix |
| Ethicon US, LLC | $52.80 | 2022-2023 | Echelon Flex, Echelon; Endopath |
| Acell, INC. | $39.74 | 2019-2020 | |
| Intuitive Surgical, INC. | $23.32 | 2022-2024 | |
| Innocoll Pharmaceuticals Limited | $15.64 | 2021 | |
| Abbvie INC. | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Trotter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.